Protein Official symbol | MET |
Aliases | MET |
Chromosomal Location | 7 |
Length | 1390 |
Uniprot ID | P08581 |
EC number | 2.7.10.1 |
Protein family Information(Pfam) | PF07714;PF01437;PF01403;PF01833; |
PDB id | 1FYR;1R0P;1R1W;1SHY;1SSL;1UX3;2G15;2RFN;2RFS;2UZX;2UZY;2WD1;2WGJ;2WKM;3A4P;3BUX;3C1X;3CCN;3CD8;3CE3;3CTH;3CTJ;3DKC;3DKF;3DKG;3EFJ;3EFK;3F66;3F82;3I5N;3L8V;3LQ8;3Q6U;3Q6W;3QTI;3R7O;3RHK;3U6H;3U6I;3VW8;3ZBX;3ZC5;3ZCL;3ZXZ;3ZZE;4AOI;4AP7;4DEG;4DEH;4DEI;4EEV;4GG5;4GG7;4IWD;4K3J;4KNB;4MXC;4O3T;4O3U;4R1V;4R1Y;4XMO;4XYF;5DG5;5EOB;5EYC;5EYD;5HLW;5HNI;5HO6;5HOA;5HOR;5HTI;5LSP;5T3Q;5UAB;5UAD;5YA5;6GCU;6I04;6SD9;6SDC;6SDD;6SDE;6UBW; |
InterPro ID | IPR013783;IPR014756;IPR002909;IPR011009;IPR031148;IPR002165;IPR000719;IPR017441;IPR016201;IPR001627;IPR036352;IPR001245;IPR008266;IPR020635;IPR016244;IPR015943; |
dbSNP | rs35469582 rs1436957498 rs56311081 rs55985569 rs34349517 rs35225896 rs35776110 rs776693512 rs33917957 rs752055485 rs771333219 rs794728016 rs34589476 rs768678989 rs56391007 rs786202724 rs121913243 rs121913244 rs121913668 rs121913675 rs121913669 rs121913673 rs121913670 rs121913671 rs121913671 rs121913246 rs121913247 rs121913677 rs121913676 rs121913245 rs1263785859 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
SHC1 | GRB2 | 0.997 |
MET | HGF | 0.997 |
HRAS | PIK3CA | 0.995 |
PTPN11 | GAB1 | 0.995 |
SOS1 | GRB2 | 0.995 |
CTNNB1 | CDH1 | 0.995 |
SEMA4D | PLXNB1 | 0.994 |
BCAR1 | CRK | 0.992 |
VEGFA | HGF | 0.992 |
BCAR1 | SRC | 0.992 |
SRC | STAT3 | 0.991 |
CTNND1 | CDH1 | 0.991 |
VEGFA | STAT3 | 0.991 |
PIK3R1 | PIK3CA | 0.99 |
PIK3CA | KRAS | 0.99 |
BCAR1 | PTK2 | 0.99 |
PTPN11 | MAPK3 | 0.987 |
VEGFA | SRC | 0.987 |
CDC42 | SRC | 0.986 |
CTNNB1 | CDH2 | 0.986 |
SRC | PTPN1 | 0.986 |
ITGA6 | ITGB1 | 0.986 |
SRC | CDH1 | 0.985 |
PTPN11 | STAT3 | 0.985 |
CDC42 | MAPK8 | 0.985 |
GRB2 | MAPK3 | 0.984 |
HRAS | SRC | 0.983 |
CDC42 | PTK2 | 0.983 |
CTNND1 | SRC | 0.983 |
STAT3 | MAPK1 | 0.983 |
PTPN11 | MAPK1 | 0.983 |
EPS15 | HGS | 0.982 |
GRB2 | GAB1 | 0.982 |
GRB2 | MAPK1 | 0.982 |
GRB2 | GAB2 | 0.982 |
GAB2 | PTPN11 | 0.981 |
ITGB1 | ITGA3 | 0.981 |
RHOA | CDH1 | 0.981 |
STAT3 | MAPK3 | 0.981 |
RHOA | CTNND1 | 0.981 |
HRAS | MAPK3 | 0.981 |
SHC1 | SOS1 | 0.981 |
MET | CDH1 | 0.98 |
SOS1 | PTPN11 | 0.98 |
GRB2 | CBL | 0.98 |
CDH1 | HGF | 0.98 |
HRAS | PTPN11 | 0.979 |
SRC | CTNNB1 | 0.979 |
MAPK3 | KRAS | 0.979 |
VEGFA | CTNNB1 | 0.979 |
HRAS | MAPK1 | 0.979 |
RHOA | MAPK1 | 0.979 |
CDC42 | CDH1 | 0.978 |
BCAR1 | CRKL | 0.977 |
RHOA | SRC | 0.977 |
SRC | HGF | 0.977 |
SRC | CRK | 0.977 |
PLXNB1 | RRAS | 0.977 |
CTNND1 | CTNNB1 | 0.977 |
STAT3 | HGF | 0.977 |
VEGFA | RHOA | 0.977 |
RHOA | MAPK8 | 0.976 |
ITGA6 | ITGB4 | 0.976 |
HRAS | SOS1 | 0.976 |
HRAS | GRB2 | 0.976 |
NRAS | PTPN11 | 0.976 |
RHOA | ARF6 | 0.975 |
RHOA | PTK2 | 0.973 |
NRAS | MAPK3 | 0.973 |
SOS1 | KRAS | 0.973 |
CDH1 | MAPK1 | 0.973 |
KRAS | MAPK1 | 0.973 |
SRC | GAB1 | 0.973 |
PTPN11 | KRAS | 0.972 |
RHOA | MAPK3 | 0.972 |
PIK3R1 | HRAS | 0.972 |
VEGFA | CDC42 | 0.971 |
GRB2 | HGF | 0.971 |
SHC1 | INPPL1 | 0.971 |
ITGB1 | ITGA2 | 0.971 |
SRC | KRAS | 0.971 |
SHC1 | MAPK3 | 0.971 |
CTNNB1 | PIK3CA | 0.971 |
GRB2 | KRAS | 0.971 |
SOS1 | SRC | 0.97 |
NRAS | MAPK1 | 0.97 |
CTNND1 | CDH2 | 0.97 |
SH3KBP1 | CBL | 0.969 |
GRB2 | PTPN1 | 0.969 |
RHOA | PLXNB1 | 0.969 |
HRAS | HGF | 0.968 |
SHC1 | MAPK1 | 0.968 |
CRK | GAB1 | 0.968 |
NRAS | PIK3CA | 0.968 |
PTK2 | PTPN11 | 0.968 |
KRAS | HGF | 0.968 |
MAPK8 | CRK | 0.967 |
RHOA | PTPN11 | 0.967 |
PTK2 | HGF | 0.967 |
PTPRJ | SRC | 0.966 |
MAPK3 | CDH1 | 0.966 |
MET | KRAS | 0.966 |
SRC | CBL | 0.966 |
PTK2 | CRK | 0.965 |
SOS1 | MAPK3 | 0.965 |
HRAS | SHC1 | 0.965 |
GRB2 | NRAS | 0.965 |
HRAS | MET | 0.965 |
SOS1 | NRAS | 0.964 |
MET | STAT3 | 0.964 |
SDC1 | HGF | 0.964 |
SHC1 | MAPK8 | 0.964 |
CDC42 | CTNND1 | 0.964 |
SOS1 | MAPK1 | 0.963 |
VEGFA | PTK2 | 0.963 |
CDC42 | CRK | 0.963 |
SH3KBP1 | MET | 0.963 |
MAPK3 | HGF | 0.963 |
PTPN1 | CRK | 0.962 |
SHC1 | HGF | 0.962 |
GRB2 | PTK2 | 0.96 |
BCAR1 | CDC42 | 0.959 |
GRB2 | STAT3 | 0.959 |
RHOA | CTNNB1 | 0.959 |
CTNNB1 | MET | 0.959 |
CRK | CBL | 0.958 |
SHC1 | PTK2 | 0.958 |
PIK3R1 | STAT3 | 0.958 |
ITGB1 | PTK2 | 0.958 |
RHOA | BCAR1 | 0.957 |
GAB2 | MAPK1 | 0.957 |
MET | PIK3CA | 0.957 |
CDC42 | CDH2 | 0.957 |
RHOA | CDH2 | 0.957 |
SRC | PIK3CA | 0.956 |
SHC1 | GAB1 | 0.956 |
GRB2 | MET | 0.956 |
SHC1 | KRAS | 0.956 |
SHC1 | CBL | 0.956 |
MAPK3 | PLCG1 | 0.956 |
PTPN11 | CBL | 0.956 |
EPS15 | ARF6 | 0.956 |
ARF6 | HGF | 0.955 |
BCAR1 | PTPN11 | 0.955 |
PIK3R1 | GRB2 | 0.955 |
CDC42 | CTNNB1 | 0.955 |
VEGFA | ITGB1 | 0.955 |
HRAS | ITGA6 | 0.954 |
ITGB1 | HGF | 0.954 |
SOS1 | CDC42 | 0.954 |
CRKL | CBL | 0.954 |
RHOA | GRB2 | 0.954 |
ITGA6 | CDH1 | 0.953 |
RHOA | CRK | 0.953 |
PIK3R1 | SRC | 0.952 |
PTPN1 | CTNNB1 | 0.952 |
HRAS | PTK2 | 0.952 |
SEMA4D | RRAS | 0.952 |
SEMA4D | RHOA | 0.951 |
GAB1 | HGF | 0.951 |
SHC1 | GAB2 | 0.951 |
VEGFA | PIK3CA | 0.951 |
HGF | MAPK1 | 0.951 |
SH3GL3 | MET | 0.951 |
PIK3R1 | KRAS | 0.951 |
SRC | ARF6 | 0.95 |
CDC42 | DOCK7 | 0.95 |
MET | CDH2 | 0.95 |
PLAUR | HGF | 0.95 |
CDC42 | ITGB1 | 0.95 |
GAB2 | CRKL | 0.949 |
MET | GAB1 | 0.949 |
MAPK8 | HGF | 0.949 |
PIK3CA | CDH1 | 0.949 |
PTPN11 | PIK3CA | 0.948 |
CTNNB1 | HGF | 0.948 |
VEGFA | GRB2 | 0.948 |
PTK2 | KRAS | 0.948 |
PIK3R1 | CTNNB1 | 0.948 |
SOS1 | CBL | 0.947 |
MAPK8 | SRC | 0.947 |
VEGFA | SHC1 | 0.947 |
SRC | NRAS | 0.947 |
SRC | PLAUR | 0.947 |
ITGB1 | SRC | 0.947 |
GRB2 | EPS15 | 0.947 |
PTPN11 | MET | 0.947 |
ITGB4 | ITGA3 | 0.947 |
CTNNB1 | PTPN11 | 0.947 |
MET | INPPL1 | 0.946 |
BCAR1 | PTPN1 | 0.946 |
MAPK3 | GAB1 | 0.945 |
SH3KBP1 | EPS15 | 0.945 |
CDC42 | HGF | 0.945 |
PTK2 | ITGA3 | 0.945 |
RHOA | SOS1 | 0.945 |
SHC1 | RHOA | 0.944 |
VEGFA | PTPN11 | 0.944 |
BCAR1 | ITGB1 | 0.944 |
NRAS | MET | 0.944 |
SOS1 | RRAS | 0.944 |
BCAR1 | MAPK8 | 0.943 |
SHC1 | MET | 0.943 |
GRB2 | PIK3CA | 0.943 |
STAT3 | PIK3CA | 0.943 |
SRC | PTPN11 | 0.943 |
CDC42 | CBL | 0.943 |
EPS15 | CBL | 0.943 |
PIK3R1 | SOS1 | 0.943 |
SRC | RRAS | 0.943 |
PIK3R1 | PTPN11 | 0.943 |
PLAUR | MET | 0.943 |
SEMA4D | MET | 0.943 |
MET | CRK | 0.942 |
CBL | PLCG1 | 0.942 |
CDH1 | ITGB4 | 0.942 |
EPS15 | SH3GL3 | 0.941 |
SRC | MAPK3 | 0.941 |
SHC1 | SRC | 0.941 |
CDC42 | MET | 0.941 |
GAB2 | CRK | 0.941 |
RHOA | ITGB1 | 0.941 |
RRAS | MAPK1 | 0.94 |
SOS1 | PLCG1 | 0.94 |
SRC | MAPK1 | 0.94 |
PTPN11 | HGF | 0.939 |
BCAR1 | CBL | 0.939 |
VEGFA | BCAR1 | 0.939 |
RHOA | MET | 0.939 |
PIK3R1 | SHC1 | 0.939 |
HRAS | MAPK8 | 0.938 |
GRB2 | PTPN11 | 0.938 |
SDC1 | MAPK3 | 0.938 |
SHC1 | PTPN1 | 0.938 |
PIK3R1 | CDC42 | 0.938 |
SDC1 | ITGA2 | 0.938 |
BCAR1 | MET | 0.937 |
MET | CBL | 0.937 |
CRKL | PTK2 | 0.937 |
ITGA6 | MET | 0.937 |
PIK3CA | HGF | 0.937 |
ITGB1 | SDC1 | 0.937 |
SOS1 | PTK2 | 0.937 |
SRC | PLCG1 | 0.936 |
ITGB1 | MET | 0.936 |
SDC1 | MET | 0.936 |
ITGA2 | ITGA3 | 0.935 |
CTNND1 | MET | 0.935 |
CRK | HGF | 0.935 |
PTK2 | ITGA2 | 0.935 |
GAB1 | MAPK1 | 0.935 |
VEGFA | PLCG1 | 0.935 |
SOS1 | PIK3CA | 0.934 |
NRAS | HGF | 0.934 |
LRIG1 | CBL | 0.934 |
CRK | ARF6 | 0.934 |
GAB2 | MAPK3 | 0.934 |
HGS | CBL | 0.933 |
CDC42 | SH3KBP1 | 0.933 |
HRAS | GAB1 | 0.933 |
ITGB1 | STAT3 | 0.933 |
PIK3R1 | NRAS | 0.932 |
SHC1 | PTPN11 | 0.932 |
PTK2 | MAPK3 | 0.932 |
PLXNB1 | MET | 0.932 |
PIK3R1 | CRK | 0.932 |
RHOA | PIK3CA | 0.932 |
SOS1 | GAB1 | 0.932 |
ARF6 | MAPK3 | 0.931 |
MAPK8 | CRKL | 0.931 |
SHC1 | PIK3CA | 0.931 |
PTPN1 | MET | 0.93 |
PTK2 | PLCG1 | 0.93 |
SH3KBP1 | SH3GL3 | 0.93 |
VEGFA | PTPRJ | 0.93 |
PTPN11 | CRK | 0.93 |
CTNND1 | PTPN11 | 0.93 |
SH3GL3 | CBL | 0.93 |
SRC | CRKL | 0.93 |
CRKL | GAB1 | 0.929 |
PTK2 | MAPK1 | 0.929 |
MAPK8 | KRAS | 0.929 |
CRKL | MET | 0.929 |
VEGFA | MET | 0.929 |
PTK2 | PIK3CA | 0.929 |
CBL | HGF | 0.929 |
GRB2 | RRAS | 0.929 |
BCAR1 | HGF | 0.929 |
PTPRJ | MET | 0.929 |
PIK3R1 | CRKL | 0.928 |
CDC42 | PLCG1 | 0.928 |
CTNND1 | HGF | 0.928 |
PIK3CA | PLCG1 | 0.928 |
VEGFA | PIK3R1 | 0.928 |
VEGFA | SOS1 | 0.928 |
CDC42 | PIK3CA | 0.928 |
RHOA | PTPN1 | 0.928 |
RHOA | CDC42 | 0.928 |
GRB2 | SRC | 0.928 |
MET | RRAS | 0.928 |
SHC1 | NRAS | 0.928 |
ITGB1 | GRB2 | 0.928 |
GRB2 | PLCG1 | 0.927 |
SDC1 | MAPK1 | 0.927 |
MET | MAPK3 | 0.927 |
ITGB1 | PLAUR | 0.927 |
GRB2 | HGS | 0.926 |
CRKL | PTPN11 | 0.926 |
SRC | PTK2 | 0.926 |
PLAUR | ITGA3 | 0.926 |
NRAS | GAB2 | 0.926 |
HRAS | GAB2 | 0.926 |
SRC | MET | 0.926 |
GAB1 | PLCG1 | 0.925 |
GAB2 | MET | 0.925 |
NRAS | PTK2 | 0.925 |
PIK3R1 | GAB2 | 0.925 |
SRC | HGS | 0.925 |
CRK | DOCK7 | 0.925 |
GRB2 | CRKL | 0.925 |
PTK2 | MET | 0.924 |
RHOA | KRAS | 0.924 |
HRAS | RHOA | 0.924 |
SOS1 | GAB2 | 0.923 |
GAB2 | PIK3CA | 0.923 |
PIK3R1 | MET | 0.923 |
PTPN1 | CDH2 | 0.923 |
MET | ITGA3 | 0.923 |
CRKL | HGF | 0.923 |
SDC1 | ITGB4 | 0.923 |
MET | LRIG1 | 0.922 |
MAPK8 | GAB1 | 0.922 |
INPPL1 | PIK3CA | 0.922 |
SHC1 | ITGB4 | 0.922 |
SHC1 | ITGB1 | 0.922 |
ITGA6 | SDC1 | 0.922 |
RHOA | NRAS | 0.921 |
ARF6 | MAPK1 | 0.921 |
MET | ITGB4 | 0.921 |
PIK3R1 | RHOA | 0.921 |
SOS1 | MET | 0.921 |
PTPN1 | HGF | 0.921 |
CDH2 | PIK3CA | 0.921 |
VEGFA | ITGA3 | 0.921 |
GRB2 | ITGB4 | 0.921 |
VEGFA | CBL | 0.921 |
MET | PLCG1 | 0.921 |
MET | DOCK7 | 0.921 |
PTK2 | RRAS | 0.921 |
MET | ITGA2 | 0.921 |
CRKL | PIK3CA | 0.92 |
HRAS | ITGB4 | 0.92 |
GAB2 | HGF | 0.92 |
CRKL | ARF6 | 0.92 |
PIK3R1 | PTPN1 | 0.92 |
MET | ARF6 | 0.92 |
HGS | HGF | 0.92 |
MET | MAPK1 | 0.92 |
EPS15 | MET | 0.92 |
MAPK8 | MET | 0.92 |
PIK3R1 | PLCG1 | 0.92 |
HGS | MET | 0.919 |
RHOA | GAB2 | 0.919 |
MAPK8 | MAPK3 | 0.919 |
ITGB1 | PIK3CA | 0.919 |
PTPN11 | CDH2 | 0.919 |
PIK3R1 | CDH1 | 0.918 |
MAPK8 | MAPK1 | 0.918 |
ITGB1 | ARF6 | 0.917 |
HGS | CDH1 | 0.917 |
SH3KBP1 | HGS | 0.917 |
PIK3R1 | PTK2 | 0.917 |
PIK3R1 | CBL | 0.917 |
ITGA2 | HGF | 0.916 |
VEGFA | GAB1 | 0.915 |
SOS1 | SH3KBP1 | 0.915 |
EPS15 | HGF | 0.915 |
SOS1 | HGF | 0.915 |
PIK3R1 | GAB1 | 0.915 |
GAB2 | KRAS | 0.915 |
PIK3R1 | ITGB1 | 0.915 |
ITGA6 | PIK3CA | 0.915 |
INPPL1 | HGF | 0.914 |
CRK | PIK3CA | 0.913 |
PIK3R1 | ITGB4 | 0.912 |
ITGB1 | CRKL | 0.912 |
PIK3R1 | BCAR1 | 0.912 |
ITGA6 | ITGA3 | 0.912 |
SHC1 | ITGA6 | 0.912 |
PIK3R1 | SH3KBP1 | 0.912 |
ITGB1 | ITGB4 | 0.911 |
SH3KBP1 | LRIG1 | 0.911 |
PTPN1 | PIK3CA | 0.911 |
ITGA2 | ITGB4 | 0.911 |
PIK3R1 | HGF | 0.91 |
PIK3R1 | ITGA6 | 0.91 |
PLCG1 | HGF | 0.91 |
SH3KBP1 | HGF | 0.91 |
LRIG1 | HGF | 0.91 |
PTPRJ | CTNNB1 | 0.91 |
HGF | ITGA3 | 0.909 |
HGS | LRIG1 | 0.909 |
PIK3CA | GAB1 | 0.909 |
SH3KBP1 | PLCG1 | 0.909 |
BCAR1 | PIK3CA | 0.908 |
PIK3R1 | CDH2 | 0.908 |
CRKL | DOCK7 | 0.908 |
CTNNB1 | HGS | 0.908 |
ITGA6 | GRB2 | 0.908 |
GAB2 | GAB1 | 0.907 |
CDH2 | CDH1 | 0.907 |
CBL | PIK3CA | 0.907 |
CTNND1 | PIK3CA | 0.907 |
PTPRJ | HGF | 0.907 |
HGS | SH3GL3 | 0.906 |
CRKL | CRK | 0.906 |
PIK3CA | ITGB4 | 0.906 |
EPS15 | LRIG1 | 0.905 |
MAPK8 | NRAS | 0.905 |
NRAS | KRAS | 0.904 |
PIK3R1 | ARF6 | 0.904 |
CDC42 | SH3GL3 | 0.904 |
PTPRJ | PLAUR | 0.904 |
SOS1 | ITGB1 | 0.904 |
HRAS | NRAS | 0.902 |
HRAS | KRAS | 0.902 |
MAPK3 | MAPK1 | 0.902 |
GAB1 | DOCK7 | 0.902 |
SH3GL3 | LRIG1 | 0.901 |
ARF6 | ITGA2 | 0.901 |
ARF6 | ITGA3 | 0.9 |
ITGA6 | ARF6 | 0.9 |
PIK3R1 | CTNND1 | 0.9 |
ARF6 | GAB1 | 0.9 |
SH3GL3 | HGF | 0.9 |
DOCK7 | HGF | 0.9 |
SOS1 | HGS | 0.9 |
ARF6 | PIK3CA | 0.9 |
# | 2885 (GRB2) | 3082 (HGF) | 5290 (PIK3CA) | 2549 (GAB1) | 999 (CDH1) | 5364 (PLXNB1) | 1398 (CRK) | 6714 (SRC) | 6774 (STAT3) | 3845 (KRAS) | 5747 (PTK2) | 5595 (MAPK3) | 1000 (CDH2) | 5770 (PTPN1) | 3688 (ITGB1) | 5599 (MAPK8) | 5594 (MAPK1) | 9146 (HGS) | 9846 (GAB2) | 5781 (PTPN11) | 3675 (ITGA3) | 1500 (CTNND1) | 6654 (SOS1) | 867 (CBL) | 1499 (CTNNB1) | 1399 (CRKL) | 6237 (RRAS) | 387 (RHOA) | 3691 (ITGB4) | 382 (ARF6) | 3265 (HRAS) | 998 (CDC42) | 3636 (INPPL1) | 3673 (ITGA2) | 6464 (SHC1) | 4893 (NRAS) | 4233 (MET) | 9564 (BCAR1) | 5335 (PLCG1) | 3655 (ITGA6) | 85440 (DOCK7) | 5329 (PLAUR) | 2060 (EPS15) | 6457 (SH3GL3) | 6382 (SDC1) | 30011 (SH3KBP1) | 5795 (PTPRJ) | 5295 (PIK3R1) | 10507 (SEMA4D) | 7422 (VEGFA) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2885 (GRB2) | 1.00 | 0.72 | 0.72 | 0.77 | 0.66 | 0.53 | 0.77 | 0.77 | 0.59 | 0.58 | 0.73 | 0.66 | 0.62 | 0.68 | 0.60 | 0.63 | 0.65 | 0.61 | 0.64 | 0.74 | 0.59 | 0.62 | 0.65 | 0.64 | 0.63 | 0.75 | 0.54 | 0.59 | 0.59 | 0.54 | 0.53 | 0.64 | 0.53 | 0.54 | 0.77 | 0.58 | 0.71 | 0.63 | 0.62 | 0.59 | 0.57 | 0.61 | 0.59 | 0.62 | 0.63 | 1.00 | 0.63 | 0.74 | 0.58 | 0.62 |
3082 (HGF) | 0.72 | 1.00 | 0.69 | 0.66 | 0.64 | 0.46 | 0.57 | 0.74 | 0.48 | 0.50 | 0.75 | 0.68 | 0.59 | 0.52 | 0.57 | 0.64 | 0.69 | 0.54 | 0.54 | 0.58 | 0.53 | 0.56 | 0.63 | 0.52 | 0.60 | 0.56 | 0.46 | 0.47 | 0.54 | 0.46 | 0.45 | 0.60 | 0.46 | 0.48 | 0.59 | 0.50 | 0.78 | 0.50 | 0.46 | 0.53 | 0.49 | 0.54 | 0.52 | 0.56 | 0.58 | 1.00 | 0.55 | 0.63 | 0.53 | 0.66 |
5290 (PIK3CA) | 0.72 | 0.69 | 1.00 | 0.86 | 0.58 | 0.37 | 0.53 | 0.77 | 0.41 | 0.41 | 0.67 | 0.79 | 0.54 | 0.46 | 0.53 | 0.73 | 0.78 | 0.47 | 0.69 | 0.68 | 0.45 | 0.47 | 0.32 | 0.53 | 0.57 | 0.48 | 0.36 | 0.39 | 0.47 | 0.37 | 0.36 | 0.61 | 0.37 | 0.41 | 0.46 | 0.41 | 0.68 | 0.41 | 0.37 | 0.47 | 0.39 | 0.46 | 0.44 | 0.44 | 0.48 | 1.00 | 0.50 | 0.69 | 0.44 | 0.52 |
2549 (GAB1) | 0.77 | 0.66 | 0.86 | 1.00 | 0.67 | 0.45 | 0.69 | 0.76 | 0.46 | 0.56 | 0.63 | 0.69 | 0.64 | 0.53 | 0.60 | 0.63 | 0.68 | 0.61 | 0.70 | 0.73 | 0.60 | 0.61 | 0.40 | 0.54 | 0.63 | 0.67 | 0.46 | 0.48 | 0.59 | 0.47 | 0.45 | 0.58 | 0.46 | 0.50 | 0.54 | 0.56 | 0.65 | 0.56 | 0.46 | 0.60 | 0.54 | 0.56 | 0.58 | 0.60 | 0.63 | 1.00 | 0.56 | 0.70 | 0.52 | 0.57 |
999 (CDH1) | 0.66 | 0.64 | 0.58 | 0.67 | 1.00 | 0.65 | 0.73 | 0.66 | 0.62 | 0.76 | 0.63 | 0.69 | 0.95 | 0.73 | 0.75 | 0.61 | 0.66 | 0.77 | 0.64 | 0.58 | 0.76 | 0.81 | 0.63 | 0.69 | 0.72 | 0.79 | 0.68 | 0.69 | 0.74 | 0.68 | 0.66 | 0.65 | 0.68 | 0.66 | 0.65 | 0.76 | 0.61 | 0.76 | 0.66 | 0.79 | 0.75 | 0.71 | 0.80 | 0.81 | 0.81 | 1.00 | 0.72 | 0.61 | 0.67 | 0.71 |
5364 (PLXNB1) | 0.53 | 0.46 | 0.37 | 0.45 | 0.65 | 1.00 | 0.59 | 0.55 | 0.48 | 0.53 | 0.47 | 0.48 | 0.60 | 0.52 | 0.70 | 0.48 | 0.46 | 0.57 | 0.44 | 0.42 | 0.55 | 0.58 | 0.57 | 0.49 | 0.61 | 0.55 | 0.46 | 0.48 | 0.56 | 0.47 | 0.45 | 0.48 | 0.46 | 0.68 | 0.53 | 0.53 | 0.67 | 0.53 | 0.46 | 0.56 | 0.51 | 0.82 | 0.54 | 0.55 | 0.58 | 1.00 | 0.54 | 0.53 | 0.84 | 0.57 |
1398 (CRK) | 0.77 | 0.57 | 0.53 | 0.69 | 0.73 | 0.59 | 1.00 | 0.71 | 0.57 | 0.71 | 0.65 | 0.61 | 0.72 | 0.72 | 0.67 | 0.57 | 0.58 | 0.76 | 0.61 | 0.67 | 0.72 | 0.75 | 0.58 | 0.72 | 0.69 | 0.81 | 0.63 | 0.67 | 0.70 | 0.63 | 0.61 | 0.62 | 0.68 | 0.62 | 0.74 | 0.71 | 0.54 | 0.77 | 0.66 | 0.71 | 0.70 | 0.71 | 0.71 | 0.74 | 0.74 | 1.00 | 0.70 | 0.64 | 0.65 | 0.64 |
6714 (SRC) | 0.77 | 0.74 | 0.77 | 0.76 | 0.66 | 0.55 | 0.71 | 1.00 | 0.55 | 0.59 | 0.80 | 0.77 | 0.64 | 0.66 | 0.66 | 0.76 | 0.77 | 0.62 | 0.66 | 0.72 | 0.61 | 0.67 | 0.53 | 0.67 | 0.69 | 0.67 | 0.56 | 0.58 | 0.65 | 0.57 | 0.57 | 0.71 | 0.59 | 0.57 | 0.64 | 0.59 | 0.74 | 0.61 | 0.58 | 0.63 | 0.59 | 0.65 | 0.63 | 0.60 | 0.63 | 1.00 | 0.63 | 0.70 | 0.62 | 0.64 |
6774 (STAT3) | 0.59 | 0.48 | 0.41 | 0.46 | 0.62 | 0.48 | 0.57 | 0.55 | 1.00 | 0.51 | 0.54 | 0.51 | 0.58 | 0.60 | 0.56 | 0.46 | 0.50 | 0.52 | 0.46 | 0.47 | 0.52 | 0.52 | 0.44 | 0.63 | 0.64 | 0.60 | 0.48 | 0.51 | 0.51 | 0.47 | 0.47 | 0.53 | 0.46 | 0.49 | 0.52 | 0.51 | 0.50 | 0.54 | 0.50 | 0.52 | 0.49 | 0.53 | 0.51 | 0.53 | 0.55 | 1.00 | 0.56 | 0.53 | 0.51 | 0.58 |
3845 (KRAS) | 0.58 | 0.50 | 0.41 | 0.56 | 0.76 | 0.53 | 0.71 | 0.59 | 0.51 | 1.00 | 0.53 | 0.57 | 0.75 | 0.61 | 0.72 | 0.49 | 0.52 | 0.82 | 0.52 | 0.46 | 0.79 | 0.82 | 0.49 | 0.57 | 0.71 | 0.70 | 0.72 | 0.59 | 0.72 | 0.59 | 0.55 | 0.54 | 0.58 | 0.67 | 0.59 | 1.00 | 0.47 | 0.80 | 0.56 | 0.76 | 0.76 | 0.68 | 0.78 | 0.85 | 0.84 | 1.00 | 0.64 | 0.55 | 0.61 | 0.62 |
5747 (PTK2) | 0.73 | 0.75 | 0.67 | 0.63 | 0.63 | 0.47 | 0.65 | 0.80 | 0.54 | 0.53 | 1.00 | 0.75 | 0.60 | 0.60 | 0.60 | 0.73 | 0.75 | 0.57 | 0.58 | 0.61 | 0.55 | 0.56 | 0.63 | 0.57 | 0.65 | 0.55 | 0.47 | 0.56 | 0.55 | 0.48 | 0.47 | 0.69 | 0.52 | 0.49 | 0.62 | 0.53 | 0.80 | 0.62 | 0.55 | 0.55 | 0.52 | 0.57 | 0.54 | 0.55 | 0.57 | 1.00 | 0.62 | 0.65 | 0.52 | 0.56 |
5595 (MAPK3) | 0.66 | 0.68 | 0.79 | 0.69 | 0.69 | 0.48 | 0.61 | 0.77 | 0.51 | 0.57 | 0.75 | 1.00 | 0.64 | 0.55 | 0.61 | 0.88 | 0.99 | 0.61 | 0.61 | 0.58 | 0.59 | 0.61 | 0.43 | 0.59 | 0.64 | 0.61 | 0.49 | 0.51 | 0.58 | 0.50 | 0.48 | 0.71 | 0.50 | 0.51 | 0.53 | 0.57 | 0.71 | 0.57 | 0.49 | 0.59 | 0.55 | 0.59 | 0.58 | 0.64 | 0.66 | 1.00 | 0.58 | 0.63 | 0.55 | 0.60 |
1000 (CDH2) | 0.62 | 0.59 | 0.54 | 0.64 | 0.95 | 0.60 | 0.72 | 0.64 | 0.58 | 0.75 | 0.60 | 0.64 | 1.00 | 0.72 | 0.72 | 0.57 | 0.61 | 0.77 | 0.61 | 0.55 | 0.76 | 0.82 | 0.59 | 0.67 | 0.73 | 0.76 | 0.65 | 0.67 | 0.73 | 0.66 | 0.63 | 0.61 | 0.65 | 0.64 | 0.63 | 0.75 | 0.56 | 0.75 | 0.63 | 0.79 | 0.74 | 0.70 | 0.80 | 0.79 | 0.79 | 1.00 | 0.71 | 0.59 | 0.65 | 0.68 |
5770 (PTPN1) | 0.68 | 0.52 | 0.46 | 0.53 | 0.73 | 0.52 | 0.72 | 0.66 | 0.60 | 0.61 | 0.60 | 0.55 | 0.72 | 1.00 | 0.65 | 0.54 | 0.53 | 0.65 | 0.55 | 0.70 | 0.64 | 0.71 | 0.49 | 0.69 | 0.70 | 0.73 | 0.55 | 0.64 | 0.62 | 0.58 | 0.55 | 0.60 | 0.63 | 0.55 | 0.67 | 0.61 | 0.49 | 0.70 | 0.66 | 0.67 | 0.60 | 0.65 | 0.67 | 0.63 | 0.64 | 1.00 | 0.79 | 0.57 | 0.59 | 0.60 |
3688 (ITGB1) | 0.60 | 0.57 | 0.53 | 0.60 | 0.75 | 0.70 | 0.67 | 0.66 | 0.56 | 0.72 | 0.60 | 0.61 | 0.72 | 0.65 | 1.00 | 0.57 | 0.58 | 0.69 | 0.58 | 0.56 | 0.75 | 0.73 | 0.57 | 0.63 | 0.71 | 0.69 | 0.66 | 0.61 | 0.72 | 0.61 | 0.59 | 0.58 | 0.61 | 0.76 | 0.62 | 0.72 | 0.61 | 0.67 | 0.60 | 0.71 | 0.66 | 0.76 | 0.71 | 0.68 | 0.69 | 1.00 | 0.63 | 0.60 | 0.72 | 0.67 |
5599 (MAPK8) | 0.63 | 0.64 | 0.73 | 0.63 | 0.61 | 0.48 | 0.57 | 0.76 | 0.46 | 0.49 | 0.73 | 0.88 | 0.57 | 0.54 | 0.57 | 1.00 | 0.88 | 0.54 | 0.56 | 0.55 | 0.53 | 0.52 | 0.48 | 0.55 | 0.62 | 0.52 | 0.43 | 0.46 | 0.52 | 0.46 | 0.43 | 0.68 | 0.44 | 0.47 | 0.52 | 0.49 | 0.66 | 0.50 | 0.45 | 0.52 | 0.48 | 0.56 | 0.51 | 0.51 | 0.54 | 1.00 | 0.54 | 0.64 | 0.51 | 0.55 |
5594 (MAPK1) | 0.65 | 0.69 | 0.78 | 0.68 | 0.66 | 0.46 | 0.58 | 0.77 | 0.50 | 0.52 | 0.75 | 0.99 | 0.61 | 0.53 | 0.58 | 0.88 | 1.00 | 0.56 | 0.60 | 0.57 | 0.55 | 0.56 | 0.41 | 0.57 | 0.62 | 0.57 | 0.46 | 0.47 | 0.55 | 0.46 | 0.45 | 0.72 | 0.46 | 0.48 | 0.51 | 0.52 | 0.71 | 0.52 | 0.46 | 0.55 | 0.50 | 0.56 | 0.54 | 0.58 | 0.61 | 1.00 | 0.55 | 0.63 | 0.52 | 0.58 |
9146 (HGS) | 0.61 | 0.54 | 0.47 | 0.61 | 0.77 | 0.57 | 0.76 | 0.62 | 0.52 | 0.82 | 0.57 | 0.61 | 0.77 | 0.65 | 0.69 | 0.54 | 0.56 | 1.00 | 0.57 | 0.50 | 0.82 | 0.84 | 0.54 | 0.62 | 0.70 | 0.73 | 0.63 | 0.63 | 0.75 | 0.64 | 0.60 | 0.59 | 0.66 | 0.62 | 0.61 | 0.82 | 0.50 | 0.82 | 0.60 | 0.78 | 0.79 | 0.76 | 0.80 | 0.86 | 0.86 | 1.00 | 0.67 | 0.57 | 0.64 | 0.64 |
9846 (GAB2) | 0.64 | 0.54 | 0.69 | 0.70 | 0.64 | 0.44 | 0.61 | 0.66 | 0.46 | 0.52 | 0.58 | 0.61 | 0.61 | 0.55 | 0.58 | 0.56 | 0.60 | 0.57 | 1.00 | 0.57 | 0.55 | 0.58 | 0.38 | 0.55 | 0.62 | 0.57 | 0.44 | 0.48 | 0.55 | 0.45 | 0.44 | 0.54 | 0.44 | 0.49 | 0.68 | 0.52 | 0.54 | 0.54 | 0.45 | 0.56 | 0.50 | 0.54 | 0.54 | 0.55 | 0.58 | 1.00 | 0.55 | 0.67 | 0.51 | 0.57 |
5781 (PTPN11) | 0.74 | 0.58 | 0.68 | 0.73 | 0.58 | 0.42 | 0.67 | 0.72 | 0.47 | 0.46 | 0.61 | 0.58 | 0.55 | 0.70 | 0.56 | 0.55 | 0.57 | 0.50 | 0.57 | 1.00 | 0.49 | 0.51 | 0.38 | 0.51 | 0.59 | 0.60 | 0.44 | 0.51 | 0.52 | 0.44 | 0.43 | 0.57 | 0.56 | 0.46 | 0.58 | 0.46 | 0.56 | 0.53 | 0.57 | 0.49 | 0.45 | 0.50 | 0.48 | 0.48 | 0.51 | 1.00 | 0.77 | 0.68 | 0.48 | 0.53 |
3675 (ITGA3) | 0.59 | 0.53 | 0.45 | 0.60 | 0.76 | 0.55 | 0.72 | 0.61 | 0.52 | 0.79 | 0.55 | 0.59 | 0.76 | 0.64 | 0.75 | 0.53 | 0.55 | 0.82 | 0.55 | 0.49 | 1.00 | 0.81 | 0.52 | 0.59 | 0.70 | 0.71 | 0.61 | 0.62 | 0.73 | 0.63 | 0.58 | 0.57 | 0.61 | 0.60 | 0.60 | 0.79 | 0.49 | 0.80 | 0.59 | 0.77 | 0.77 | 0.71 | 0.78 | 0.84 | 0.84 | 1.00 | 0.66 | 0.56 | 0.63 | 0.67 |
1500 (CTNND1) | 0.62 | 0.56 | 0.47 | 0.61 | 0.81 | 0.58 | 0.75 | 0.67 | 0.52 | 0.82 | 0.56 | 0.61 | 0.82 | 0.71 | 0.73 | 0.52 | 0.56 | 0.84 | 0.58 | 0.51 | 0.81 | 1.00 | 0.54 | 0.69 | 0.74 | 0.80 | 0.63 | 0.63 | 0.79 | 0.64 | 0.60 | 0.58 | 0.63 | 0.62 | 0.68 | 0.82 | 0.50 | 0.82 | 0.62 | 0.87 | 0.79 | 0.74 | 0.90 | 0.86 | 0.86 | 1.00 | 0.68 | 0.61 | 0.71 | 0.69 |
6654 (SOS1) | 0.65 | 0.63 | 0.32 | 0.40 | 0.63 | 0.57 | 0.58 | 0.53 | 0.44 | 0.49 | 0.63 | 0.43 | 0.59 | 0.49 | 0.57 | 0.48 | 0.41 | 0.54 | 0.38 | 0.38 | 0.52 | 0.54 | 1.00 | 0.46 | 0.60 | 0.53 | 0.41 | 0.44 | 0.53 | 0.42 | 0.41 | 0.45 | 0.41 | 0.46 | 0.67 | 0.49 | 0.58 | 0.49 | 0.41 | 0.53 | 0.47 | 0.51 | 0.51 | 0.52 | 0.55 | 1.00 | 0.52 | 0.53 | 0.49 | 0.56 |
867 (CBL) | 0.64 | 0.52 | 0.53 | 0.54 | 0.69 | 0.49 | 0.72 | 0.67 | 0.63 | 0.57 | 0.57 | 0.59 | 0.67 | 0.69 | 0.63 | 0.55 | 0.57 | 0.62 | 0.55 | 0.51 | 0.59 | 0.69 | 0.46 | 1.00 | 0.65 | 0.63 | 0.51 | 0.55 | 0.59 | 0.51 | 0.50 | 0.67 | 0.52 | 0.52 | 0.65 | 0.57 | 0.50 | 0.61 | 0.53 | 0.65 | 0.56 | 0.60 | 0.64 | 0.60 | 0.62 | 1.00 | 0.61 | 0.57 | 0.57 | 0.59 |
1499 (CTNNB1) | 0.63 | 0.60 | 0.57 | 0.63 | 0.72 | 0.61 | 0.69 | 0.69 | 0.64 | 0.71 | 0.65 | 0.64 | 0.73 | 0.70 | 0.71 | 0.62 | 0.62 | 0.70 | 0.62 | 0.59 | 0.70 | 0.74 | 0.60 | 0.65 | 1.00 | 0.70 | 0.66 | 0.65 | 0.68 | 0.65 | 0.64 | 0.63 | 0.63 | 0.65 | 0.63 | 0.71 | 0.60 | 0.70 | 0.64 | 0.71 | 0.68 | 0.70 | 0.71 | 0.69 | 0.72 | 1.00 | 0.67 | 0.65 | 0.65 | 0.64 |
1399 (CRKL) | 0.75 | 0.56 | 0.48 | 0.67 | 0.79 | 0.55 | 0.81 | 0.67 | 0.60 | 0.70 | 0.55 | 0.61 | 0.76 | 0.73 | 0.69 | 0.52 | 0.57 | 0.73 | 0.57 | 0.60 | 0.71 | 0.80 | 0.53 | 0.63 | 0.70 | 1.00 | 0.60 | 0.61 | 0.69 | 0.61 | 0.59 | 0.59 | 0.59 | 0.59 | 0.65 | 0.70 | 0.53 | 0.70 | 0.58 | 0.76 | 0.69 | 0.65 | 0.77 | 0.78 | 0.78 | 1.00 | 0.63 | 0.61 | 0.61 | 0.64 |
6237 (RRAS) | 0.54 | 0.46 | 0.36 | 0.46 | 0.68 | 0.46 | 0.63 | 0.56 | 0.48 | 0.72 | 0.47 | 0.49 | 0.65 | 0.55 | 0.66 | 0.43 | 0.46 | 0.63 | 0.44 | 0.44 | 0.61 | 0.63 | 0.41 | 0.51 | 0.66 | 0.60 | 1.00 | 0.85 | 0.60 | 0.88 | 0.92 | 0.72 | 0.49 | 0.59 | 0.54 | 0.72 | 0.42 | 0.58 | 0.49 | 0.61 | 0.56 | 0.57 | 0.60 | 0.62 | 0.65 | 1.00 | 0.59 | 0.51 | 0.53 | 0.59 |
387 (RHOA) | 0.59 | 0.47 | 0.39 | 0.48 | 0.69 | 0.48 | 0.67 | 0.58 | 0.51 | 0.59 | 0.56 | 0.51 | 0.67 | 0.64 | 0.61 | 0.46 | 0.47 | 0.63 | 0.48 | 0.51 | 0.62 | 0.63 | 0.44 | 0.55 | 0.65 | 0.61 | 0.85 | 1.00 | 0.61 | 0.89 | 0.90 | 0.78 | 0.51 | 0.53 | 0.58 | 0.59 | 0.44 | 0.71 | 0.59 | 0.62 | 0.58 | 0.59 | 0.61 | 0.63 | 0.65 | 1.00 | 0.68 | 0.52 | 0.54 | 0.59 |
3691 (ITGB4) | 0.59 | 0.54 | 0.47 | 0.59 | 0.74 | 0.56 | 0.70 | 0.65 | 0.51 | 0.72 | 0.55 | 0.58 | 0.73 | 0.62 | 0.72 | 0.52 | 0.55 | 0.75 | 0.55 | 0.52 | 0.73 | 0.79 | 0.53 | 0.59 | 0.68 | 0.69 | 0.60 | 0.61 | 1.00 | 0.61 | 0.57 | 0.56 | 0.60 | 0.61 | 0.63 | 0.72 | 0.50 | 0.73 | 0.58 | 0.88 | 0.71 | 0.69 | 0.73 | 0.76 | 0.76 | 1.00 | 0.64 | 0.58 | 0.64 | 0.63 |
382 (ARF6) | 0.54 | 0.46 | 0.37 | 0.47 | 0.68 | 0.47 | 0.63 | 0.57 | 0.47 | 0.59 | 0.48 | 0.50 | 0.66 | 0.58 | 0.61 | 0.46 | 0.46 | 0.64 | 0.45 | 0.44 | 0.63 | 0.64 | 0.42 | 0.51 | 0.65 | 0.61 | 0.88 | 0.89 | 0.61 | 1.00 | 0.93 | 0.78 | 0.50 | 0.52 | 0.54 | 0.59 | 0.43 | 0.60 | 0.50 | 0.62 | 0.57 | 0.60 | 0.61 | 0.63 | 0.66 | 1.00 | 0.60 | 0.51 | 0.54 | 0.59 |
3265 (HRAS) | 0.53 | 0.45 | 0.36 | 0.45 | 0.66 | 0.45 | 0.61 | 0.57 | 0.47 | 0.55 | 0.47 | 0.48 | 0.63 | 0.55 | 0.59 | 0.43 | 0.45 | 0.60 | 0.44 | 0.43 | 0.58 | 0.60 | 0.41 | 0.50 | 0.64 | 0.59 | 0.92 | 0.90 | 0.57 | 0.93 | 1.00 | 0.76 | 0.48 | 0.52 | 0.54 | 0.55 | 0.42 | 0.55 | 0.48 | 0.58 | 0.53 | 0.55 | 0.57 | 0.58 | 0.66 | 1.00 | 0.57 | 0.50 | 0.52 | 0.59 |
998 (CDC42) | 0.64 | 0.60 | 0.61 | 0.58 | 0.65 | 0.48 | 0.62 | 0.71 | 0.53 | 0.54 | 0.69 | 0.71 | 0.61 | 0.60 | 0.58 | 0.68 | 0.72 | 0.59 | 0.54 | 0.57 | 0.57 | 0.58 | 0.45 | 0.67 | 0.63 | 0.59 | 0.72 | 0.78 | 0.56 | 0.78 | 0.76 | 1.00 | 0.50 | 0.51 | 0.56 | 0.54 | 0.60 | 0.61 | 0.55 | 0.57 | 0.53 | 0.59 | 0.56 | 0.59 | 0.61 | 1.00 | 0.63 | 0.57 | 0.53 | 0.59 |
3636 (INPPL1) | 0.53 | 0.46 | 0.37 | 0.46 | 0.68 | 0.46 | 0.68 | 0.59 | 0.46 | 0.58 | 0.52 | 0.50 | 0.65 | 0.63 | 0.61 | 0.44 | 0.46 | 0.66 | 0.44 | 0.56 | 0.61 | 0.63 | 0.41 | 0.52 | 0.63 | 0.59 | 0.49 | 0.51 | 0.60 | 0.50 | 0.48 | 0.50 | 1.00 | 0.51 | 0.53 | 0.58 | 0.42 | 0.59 | 0.57 | 0.61 | 0.56 | 0.59 | 0.60 | 0.62 | 0.65 | 1.00 | 0.72 | 0.51 | 0.54 | 0.58 |
3673 (ITGA2) | 0.54 | 0.48 | 0.41 | 0.50 | 0.66 | 0.68 | 0.62 | 0.57 | 0.49 | 0.67 | 0.49 | 0.51 | 0.64 | 0.55 | 0.76 | 0.47 | 0.48 | 0.62 | 0.49 | 0.46 | 0.60 | 0.62 | 0.46 | 0.52 | 0.65 | 0.59 | 0.59 | 0.53 | 0.61 | 0.52 | 0.52 | 0.51 | 0.51 | 1.00 | 0.56 | 0.67 | 0.59 | 0.59 | 0.50 | 0.60 | 0.57 | 0.69 | 0.60 | 0.61 | 0.63 | 1.00 | 0.57 | 0.54 | 0.68 | 0.60 |
6464 (SHC1) | 0.77 | 0.59 | 0.46 | 0.54 | 0.65 | 0.53 | 0.74 | 0.64 | 0.52 | 0.59 | 0.62 | 0.53 | 0.63 | 0.67 | 0.62 | 0.52 | 0.51 | 0.61 | 0.68 | 0.58 | 0.60 | 0.68 | 0.67 | 0.65 | 0.63 | 0.65 | 0.54 | 0.58 | 0.63 | 0.54 | 0.54 | 0.56 | 0.53 | 0.56 | 1.00 | 0.59 | 0.56 | 0.63 | 0.62 | 0.60 | 0.58 | 0.64 | 0.60 | 0.61 | 0.62 | 1.00 | 0.62 | 0.73 | 0.61 | 0.63 |
4893 (NRAS) | 0.58 | 0.50 | 0.41 | 0.56 | 0.76 | 0.53 | 0.71 | 0.59 | 0.51 | 1.00 | 0.53 | 0.57 | 0.75 | 0.61 | 0.72 | 0.49 | 0.52 | 0.82 | 0.52 | 0.46 | 0.79 | 0.82 | 0.49 | 0.57 | 0.71 | 0.70 | 0.72 | 0.59 | 0.72 | 0.59 | 0.55 | 0.54 | 0.58 | 0.67 | 0.59 | 1.00 | 0.47 | 0.80 | 0.56 | 0.76 | 0.76 | 0.68 | 0.78 | 0.85 | 0.84 | 1.00 | 0.64 | 0.55 | 0.61 | 0.62 |
4233 (MET) | 0.71 | 0.78 | 0.68 | 0.65 | 0.61 | 0.67 | 0.54 | 0.74 | 0.50 | 0.47 | 0.80 | 0.71 | 0.56 | 0.49 | 0.61 | 0.66 | 0.71 | 0.50 | 0.54 | 0.56 | 0.49 | 0.50 | 0.58 | 0.50 | 0.60 | 0.53 | 0.42 | 0.44 | 0.50 | 0.43 | 0.42 | 0.60 | 0.42 | 0.59 | 0.56 | 0.47 | 1.00 | 0.47 | 0.42 | 0.50 | 0.46 | 0.66 | 0.49 | 0.52 | 0.54 | 1.00 | 0.51 | 0.65 | 0.67 | 0.56 |
9564 (BCAR1) | 0.63 | 0.50 | 0.41 | 0.56 | 0.76 | 0.53 | 0.77 | 0.61 | 0.54 | 0.80 | 0.62 | 0.57 | 0.75 | 0.70 | 0.67 | 0.50 | 0.52 | 0.82 | 0.54 | 0.53 | 0.80 | 0.82 | 0.49 | 0.61 | 0.70 | 0.70 | 0.58 | 0.71 | 0.73 | 0.60 | 0.55 | 0.61 | 0.59 | 0.59 | 0.63 | 0.80 | 0.47 | 1.00 | 0.67 | 0.76 | 0.76 | 0.69 | 0.78 | 0.85 | 0.85 | 1.00 | 0.75 | 0.56 | 0.61 | 0.62 |
5335 (PLCG1) | 0.62 | 0.46 | 0.37 | 0.46 | 0.66 | 0.46 | 0.66 | 0.58 | 0.50 | 0.56 | 0.55 | 0.49 | 0.63 | 0.66 | 0.60 | 0.45 | 0.46 | 0.60 | 0.45 | 0.57 | 0.59 | 0.62 | 0.41 | 0.53 | 0.64 | 0.58 | 0.49 | 0.59 | 0.58 | 0.50 | 0.48 | 0.55 | 0.57 | 0.50 | 0.62 | 0.56 | 0.42 | 0.67 | 1.00 | 0.59 | 0.54 | 0.58 | 0.58 | 0.59 | 0.62 | 1.00 | 0.74 | 0.56 | 0.53 | 0.57 |
3655 (ITGA6) | 0.59 | 0.53 | 0.47 | 0.60 | 0.79 | 0.56 | 0.71 | 0.63 | 0.52 | 0.76 | 0.55 | 0.59 | 0.79 | 0.67 | 0.71 | 0.52 | 0.55 | 0.78 | 0.56 | 0.49 | 0.77 | 0.87 | 0.53 | 0.65 | 0.71 | 0.76 | 0.61 | 0.62 | 0.88 | 0.62 | 0.58 | 0.57 | 0.61 | 0.60 | 0.60 | 0.76 | 0.50 | 0.76 | 0.59 | 1.00 | 0.74 | 0.68 | 0.84 | 0.80 | 0.80 | 1.00 | 0.65 | 0.56 | 0.63 | 0.63 |
85440 (DOCK7) | 0.57 | 0.49 | 0.39 | 0.54 | 0.75 | 0.51 | 0.70 | 0.59 | 0.49 | 0.76 | 0.52 | 0.55 | 0.74 | 0.60 | 0.66 | 0.48 | 0.50 | 0.79 | 0.50 | 0.45 | 0.77 | 0.79 | 0.47 | 0.56 | 0.68 | 0.69 | 0.56 | 0.58 | 0.71 | 0.57 | 0.53 | 0.53 | 0.56 | 0.57 | 0.58 | 0.76 | 0.46 | 0.76 | 0.54 | 0.74 | 1.00 | 0.67 | 0.75 | 0.82 | 0.82 | 1.00 | 0.63 | 0.54 | 0.59 | 0.62 |
5329 (PLAUR) | 0.61 | 0.54 | 0.46 | 0.56 | 0.71 | 0.82 | 0.71 | 0.65 | 0.53 | 0.68 | 0.57 | 0.59 | 0.70 | 0.65 | 0.76 | 0.56 | 0.56 | 0.76 | 0.54 | 0.50 | 0.71 | 0.74 | 0.51 | 0.60 | 0.70 | 0.65 | 0.57 | 0.59 | 0.69 | 0.60 | 0.55 | 0.59 | 0.59 | 0.69 | 0.64 | 0.68 | 0.66 | 0.69 | 0.58 | 0.68 | 0.67 | 1.00 | 0.68 | 0.71 | 0.72 | 1.00 | 0.64 | 0.59 | 0.87 | 0.66 |
2060 (EPS15) | 0.59 | 0.52 | 0.44 | 0.58 | 0.80 | 0.54 | 0.71 | 0.63 | 0.51 | 0.78 | 0.54 | 0.58 | 0.80 | 0.67 | 0.71 | 0.51 | 0.54 | 0.80 | 0.54 | 0.48 | 0.78 | 0.90 | 0.51 | 0.64 | 0.71 | 0.77 | 0.60 | 0.61 | 0.73 | 0.61 | 0.57 | 0.56 | 0.60 | 0.60 | 0.60 | 0.78 | 0.49 | 0.78 | 0.58 | 0.84 | 0.75 | 0.68 | 1.00 | 0.82 | 0.82 | 1.00 | 0.65 | 0.56 | 0.62 | 0.63 |
6457 (SH3GL3) | 0.62 | 0.56 | 0.44 | 0.60 | 0.81 | 0.55 | 0.74 | 0.60 | 0.53 | 0.85 | 0.55 | 0.64 | 0.79 | 0.63 | 0.68 | 0.51 | 0.58 | 0.86 | 0.55 | 0.48 | 0.84 | 0.86 | 0.52 | 0.60 | 0.69 | 0.78 | 0.62 | 0.63 | 0.76 | 0.63 | 0.58 | 0.59 | 0.62 | 0.61 | 0.61 | 0.85 | 0.52 | 0.85 | 0.59 | 0.80 | 0.82 | 0.71 | 0.82 | 1.00 | 0.96 | 1.00 | 0.66 | 0.56 | 0.63 | 0.66 |
6382 (SDC1) | 0.63 | 0.58 | 0.48 | 0.63 | 0.81 | 0.58 | 0.74 | 0.63 | 0.55 | 0.84 | 0.57 | 0.66 | 0.79 | 0.64 | 0.69 | 0.54 | 0.61 | 0.86 | 0.58 | 0.51 | 0.84 | 0.86 | 0.55 | 0.62 | 0.72 | 0.78 | 0.65 | 0.65 | 0.76 | 0.66 | 0.66 | 0.61 | 0.65 | 0.63 | 0.62 | 0.84 | 0.54 | 0.85 | 0.62 | 0.80 | 0.82 | 0.72 | 0.82 | 0.96 | 1.00 | 1.00 | 0.68 | 0.58 | 0.65 | 0.67 |
30011 (SH3KBP1) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
5795 (PTPRJ) | 0.63 | 0.55 | 0.50 | 0.56 | 0.72 | 0.54 | 0.70 | 0.63 | 0.56 | 0.64 | 0.62 | 0.58 | 0.71 | 0.79 | 0.63 | 0.54 | 0.55 | 0.67 | 0.55 | 0.77 | 0.66 | 0.68 | 0.52 | 0.61 | 0.67 | 0.63 | 0.59 | 0.68 | 0.64 | 0.60 | 0.57 | 0.63 | 0.72 | 0.57 | 0.62 | 0.64 | 0.51 | 0.75 | 0.74 | 0.65 | 0.63 | 0.64 | 0.65 | 0.66 | 0.68 | 1.00 | 1.00 | 0.56 | 0.60 | 0.66 |
5295 (PIK3R1) | 0.74 | 0.63 | 0.69 | 0.70 | 0.61 | 0.53 | 0.64 | 0.70 | 0.53 | 0.55 | 0.65 | 0.63 | 0.59 | 0.57 | 0.60 | 0.64 | 0.63 | 0.57 | 0.67 | 0.68 | 0.56 | 0.61 | 0.53 | 0.57 | 0.65 | 0.61 | 0.51 | 0.52 | 0.58 | 0.51 | 0.50 | 0.57 | 0.51 | 0.54 | 0.73 | 0.55 | 0.65 | 0.56 | 0.56 | 0.56 | 0.54 | 0.59 | 0.56 | 0.56 | 0.58 | 1.00 | 0.56 | 1.00 | 0.57 | 0.57 |
10507 (SEMA4D) | 0.58 | 0.53 | 0.44 | 0.52 | 0.67 | 0.84 | 0.65 | 0.62 | 0.51 | 0.61 | 0.52 | 0.55 | 0.65 | 0.59 | 0.72 | 0.51 | 0.52 | 0.64 | 0.51 | 0.48 | 0.63 | 0.71 | 0.49 | 0.57 | 0.65 | 0.61 | 0.53 | 0.54 | 0.64 | 0.54 | 0.52 | 0.53 | 0.54 | 0.68 | 0.61 | 0.61 | 0.67 | 0.61 | 0.53 | 0.63 | 0.59 | 0.87 | 0.62 | 0.63 | 0.65 | 1.00 | 0.60 | 0.57 | 1.00 | 0.65 |
7422 (VEGFA) | 0.62 | 0.66 | 0.52 | 0.57 | 0.71 | 0.57 | 0.64 | 0.64 | 0.58 | 0.62 | 0.56 | 0.60 | 0.68 | 0.60 | 0.67 | 0.55 | 0.58 | 0.64 | 0.57 | 0.53 | 0.67 | 0.69 | 0.56 | 0.59 | 0.64 | 0.64 | 0.59 | 0.59 | 0.63 | 0.59 | 0.59 | 0.59 | 0.58 | 0.60 | 0.63 | 0.62 | 0.56 | 0.62 | 0.57 | 0.63 | 0.62 | 0.66 | 0.63 | 0.66 | 0.67 | 1.00 | 0.66 | 0.57 | 0.65 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MET | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 1.5 | RT-qPCR | Western US | C57BL/6 mice | –5.1 | 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
MET | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 2.7 | RT-qPCR | Western US | C57BL/6 mice | –5.1 | 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|---|---|---|---|---|---|
E2F1 | 1869 | MET | 4233 | proximal_filtered | 22955619 | TRANSFAC |
PAX3 | 5077 | MET | 4233 | Unknown | 10426567 | TRUSST |
SP1 | 6667 | MET | 4233 | Unknown | 8188699 | TRUSST |
TP53 | 7157 | MET | 4233 | Activation | 8288055 | TRUSST |
FOXP2 | 93986 | MET | 4233 | Repression | 17426099 | TRUSST |
HIF1A | 3091 | MET | 4233 | Unknown | 10601637 | TRUSST |
SMAD7 | 4092 | MET | 4233 | Activation | 17300785 | TRUSST |
YBX1 | 4904 | MET | 4233 | Activation | 8288055 | TRUSST |
MITF | 4286 | MET | 4233 | Activation | 7568086 | TRUSST |
PAX5 | 5079 | MET | 4233 | Unknown | 10567574 | TRUSST |
PAX6 | 5080 | MET | 4233 | Unknown | 23530236 | TRUSST |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT000185 | hsa-miR-206 | Homo sapiens | MET | 4233 | Homo sapiens | Western blot | Functional MTI | 19620785 |
MIRT000185 | hsa-miR-206 | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 19710019 |
MIRT000185 | hsa-miR-206 | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR//ChIP//Luciferase reporter assay//Western blot//Northern blot | Functional MTI | 20388878 |
MIRT000185 | hsa-miR-206 | Homo sapiens | MET | 4233 | Homo sapiens | FACS//Flow//Immunohistochemistry//qRT-PCR//Western blot | Functional MTI | 26186594 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 19461653 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 20198305 |
MIRT000758 | hsa-miR-34b-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 19461653 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | ELISA//Luciferase reporter assay//qRT-PCR | Functional MTI | 24983493 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Flow//Immunofluorescence//In situ hybridization//qRT-PCR//Western blot | Functional MTI | 26313360 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR//Western blot | Functional MTI | 19006648 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 19773441 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22159222 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR | Functional MTI (Weak) | 21240262 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Microarray//Western blot//RTPCR | Functional MTI | 20924086 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 23922103 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot//Northern blot | Functional MTI | 19029026 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunofluorescence//qRT-PCR//Western blot | Functional MTI | 23970470 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunohistochemistry//qRT-PCR//Western blot | Functional MTI | 26238271 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Flow//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 27513895 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22419847 |
MIRT000757 | hsa-miR-34c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Next Generation Sequencing (NGS)//qRT-PCR//Western blot | Functional MTI | 26795575 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 19461653 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 18834857 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR//Western blot | Functional MTI | 20309880 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22457788 |
MIRT000759 | hsa-miR-34a-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunoblot//qRT-PCR | Functional MTI (Weak) | 28250026 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 27247259 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | pSILAC//Proteomics | Functional MTI (Weak) | 18668040 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Microarray | Functional MTI (Weak) | 18668037 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 19710019 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 18818206 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 18593903 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR | Functional MTI (Weak) | 21169019 |
MIRT001357 | hsa-miR-1-3p | Homo sapiens | MET | 4233 | Homo sapiens | Microarray//qRT-PCR//Western blot | Functional MTI | 25874496 |
MIRT001969 | hsa-miR-199a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26051997 |
MIRT001969 | hsa-miR-199a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 25839163 |
MIRT001969 | hsa-miR-199a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 18456660 |
MIRT001969 | hsa-miR-199a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Immunofluorescence//Microarray//QRTPCRWestern blot | Functional MTI | 24810336 |
MIRT004292 | hsa-miR-23b-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot//Reporter assay;Western blot;qRT-PCR | Functional MTI | 19490101 |
MIRT004292 | hsa-miR-23b-3p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR//Luciferase reporter assay//Western blot | Functional MTI | 25405368 |
MIRT004292 | hsa-miR-23b-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 28077801 |
MIRT004825 | hsa-miR-34b-3p | Homo sapiens | MET | 4233 | Homo sapiens | Microarray//Western blot//RTPCR | Functional MTI | 20924086 |
MIRT005024 | hsa-miR-562 | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Non-Functional MTI | 19789318 |
MIRT005167 | hsa-miR-30a-5p | Homo sapiens | MET | 4233 | Homo sapiens | pSILAC//Proteomics;Other | Functional MTI (Weak) | 18668040 |
MIRT005458 | hsa-miR-340-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21692045 |
MIRT004825 | hsa-miR-34b-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22419847 |
MIRT006346 | hsa-miR-449a | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western Blot//qRT-PCR | Functional MTI | 23734217 |
MIRT006346 | hsa-miR-449a | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 21418558 |
MIRT006346 | hsa-miR-449a | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26471185 |
MIRT006351 | hsa-miR-449b-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 21418558 |
MIRT006778 | hsa-miR-198 | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 21658389 |
MIRT007137 | hsa-miR-130a-3p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR | Functional MTI (Weak) | 23418453 |
MIRT016691 | hsa-miR-133b | Homo sapiens | MET | 4233 | Homo sapiens | Western blot | Functional MTI | 24391788 |
MIRT016691 | hsa-miR-133b | Homo sapiens | MET | 4233 | Homo sapiens | Reporter assay | Functional MTI | 20505319 |
MIRT035528 | hsa-miR-31-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunoblot//Immunohistochemistry//Luciferase reporter assay//qRT-PCR | Functional MTI | 22948084 |
MIRT035528 | hsa-miR-31-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 23552883 |
MIRT035528 | hsa-miR-31-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 23553486 |
MIRT035879 | hsa-miR-1303 | Homo sapiens | MET | 4233 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT044529 | hsa-miR-320a | Homo sapiens | MET | 4233 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT053148 | hsa-miR-27a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23650389 |
MIRT053225 | hsa-miR-137 | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23151846 |
MIRT054232 | hsa-miR-410-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22750473 |
MIRT054388 | hsa-miR-148a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Immunoblot//Immunofluorescence//Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 24013226 |
MIRT319319 | hsa-miR-449c-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26141986 |
MIRT437442 | hsa-miR-409-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23820886 |
MIRT437858 | hsa-miR-101-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 23618864 |
MIRT438343 | hsa-miR-144-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26250785 |
MIRT438343 | hsa-miR-144-3p | Homo sapiens | MET | 4233 | Homo sapiens | ChIP-seq//Luciferase reporter assay//Microarray//qRT-PCR//Western blot | Functional MTI | 25927670 |
MIRT438442 | hsa-miR-7515 | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23087254 |
MIRT440251 | hsa-miR-218-5p | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 23212916 |
MIRT732083 | hsa-miR-139-5p | Homo sapiens | MET | 4233 | Homo sapiens | Immunofluorescence//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26497851 |
MIRT731338 | hsa-miR-433-3p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 26844702 |
MIRT732479 | hsa-miR-27b-3p | Homo sapiens | MET | 4233 | Homo sapiens | qRT-PCR//Luciferase reporter assay//Western blot | Functional MTI | 25405368 |
MIRT733070 | hsa-miR-34a-3p | Homo sapiens | MET | 4233 | Homo sapiens | Western blot | Functional MTI | 27364974 |
MIRT734958 | hsa-miR-1-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay | Functional MTI | 27169691 |
MIRT735298 | hsa-miR-144-5p | Homo sapiens | MET | 4233 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 25961751 |
MIRT790064 | hsa-miR-1257 | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790069 | hsa-miR-1262 | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790503 | hsa-miR-4506 | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790393 | hsa-miR-425-5p | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790571 | hsa-miR-4701-3p | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790733 | hsa-miR-545-5p | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT790905 | hsa-miR-6736-5p | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
MIRT791134 | hsa-miR-802 | Homo sapiens | MET | 4233 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 28735896 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
4233 | GO:0007166 | cell surface receptor signaling pathway | GOTERM_BP_DIRECT |
4233 | GO:0010507 | negative regulation of autophagy | GOTERM_BP_DIRECT |
4233 | GO:0071526 | semaphorin-plexin signaling pathway | GOTERM_BP_DIRECT |
4233 | GO:2001028 | positive regulation of endothelial cell chemotaxis | GOTERM_BP_DIRECT |
4233 | GO:0004713 | protein serine/threonine/tyrosine kinase activity | GOTERM_MF_DIRECT |
4233 | GO:0005886 | plasma membrane | GOTERM_CC_DIRECT |
4233 | GO:0005887 | integral component of plasma membrane | GOTERM_CC_DIRECT |
4233 | GO:0007165 | signal transduction | GOTERM_BP_DIRECT |
4233 | GO:0008283 | cell proliferation | GOTERM_BP_DIRECT |
4233 | GO:0050918 | positive chemotaxis | GOTERM_BP_DIRECT |
4233 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
4233 | GO:0005524 | ATP binding | GOTERM_MF_DIRECT |
4233 | GO:0017154 | Wnt-protein binding | GOTERM_MF_DIRECT |
4233 | GO:0019903 | phosphatase binding | GOTERM_MF_DIRECT |
4233 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
4233 | GO:0009925 | basal plasma membrane | GOTERM_CC_DIRECT |
4233 | GO:0009986 | cell surface | GOTERM_CC_DIRECT |
4233 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | GOTERM_BP_DIRECT |
4233 | GO:0048012 | hepatocyte growth factor receptor signaling pathway | GOTERM_BP_DIRECT |
4233 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death | GOTERM_BP_DIRECT |
4233 | GO:0005008 | olfactory receptor activity | GOTERM_MF_DIRECT |
4233 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
4233 | GO:0001886 | endothelial cell morphogenesis | GOTERM_BP_DIRECT |
4233 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | GOTERM_BP_DIRECT |
4233 | GO:0018108 | peptidyl-tyrosine phosphorylation | GOTERM_BP_DIRECT |
4233 | GO:0048754 | branching morphogenesis of an epithelial tube | GOTERM_BP_DIRECT |
4233 | GO:0004672 | protein kinase activity | GOTERM_MF_DIRECT |
4233 | GO:0004714 | protein tyrosine kinase activity | GOTERM_MF_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
4233 | hsa04014 | Ras signaling pathway |
4233 | hsa04015 | Rap1 signaling pathway |
4233 | hsa04151 | PI3K-Akt signaling pathway |
4233 | hsa04360 | Axon guidance |
4233 | hsa04520 | Adherens junction |
4233 | hsa04510 | Focal adhesion |
4233 | hsa05100 | Bacterial invasion of epithelial cells |
4233 | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
4233 | hsa05202 | Transcriptional misregulation in cancer |
4233 | hsa05200 | Pathways in cancer |
4233 | hsa05144 | Malaria |
4233 | hsa05206 | MicroRNAs in cancer |
4233 | hsa05218 | Melanoma |
4233 | hsa05205 | Proteoglycans in cancer |
4233 | hsa05211 | Renal cell carcinoma |
4233 | hsa05230 | Central carbon metabolism in cancer |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
MET | 4233 | Benign neoplasm of stomach | C0153943 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant Neoplasms | C0006826 | Neoplastic Process | 0.4 | 0.405 | 0.793 | group |
MET | 4233 | Carcinoma in situ of stomach | C0154060 | Neoplastic Process | 0.31 | 0.405 | 0.793 | disease |
MET | 4233 | Neoplasm of uncertain or unknown behavior of stomach | C0496905 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Stomach Carcinoma | C0699791 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Squamous cell carcinoma of the head and neck | C1168401 | Neoplastic Process | 0.37 | 0.405 | 0.793 | disease |
MET | 4233 | Adenocarcinoma of large intestine | C1319315 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Non-Small Cell Lung Carcinoma | C0007131 | Neoplastic Process | 0.6 | 0.405 | 0.793 | disease |
MET | 4233 | Stomach Neoplasms | C0038356 | Neoplastic Process | 0.56 | 0.405 | 0.793 | group |
MET | 4233 | Conventional (Clear Cell) Renal Cell Carcinoma | C0279702 | Neoplastic Process | 0.57 | 0.405 | 0.793 | disease |
MET | 4233 | Papillary Renal Cell Carcinoma | C1306837 | Neoplastic Process | 0.8 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of stomach | C0024623 | Neoplastic Process | 0.7 | 0.405 | 0.793 | disease |
MET | 4233 | Liver carcinoma | C2239176 | Neoplastic Process | 0.8 | 0.405 | 0.793 | disease |
MET | 4233 | Benign neoplasm of adrenal gland | C0154040 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant Adrenal Medulla Neoplasm | C0344456 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of aortic body and other paraganglia | C0438413 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Benign neoplasm of aortic body and other paraganglia | C0154045 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Renal Cell Carcinoma | C0007134 | Neoplastic Process | 0.5 | 0.405 | 0.793 | disease |
MET | 4233 | Squamous cell carcinoma | C0007137 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Hepatitis, Chronic | C0019189 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Hepatoma, Morris | C0019207 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Hepatoma, Novikoff | C0019208 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Liver Neoplasms, Experimental | C0023904 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.405 | 0.793 | group |
MET | 4233 | Neoplasm Invasiveness | C0027626 | Pathologic Function | 0.3 | 0.405 | 0.793 | phenotype |
MET | 4233 | Osteosarcoma | C0029463 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Adenocarcinoma, Basal Cell | C0205641 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Anaplastic astrocytoma | C0334579 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Giant Cell Glioblastoma | C0334588 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Adenocarcinoma | C0001418 | Neoplastic Process | 0.4 | 0.405 | 0.793 | group |
MET | 4233 | Carcinoma | C0007097 | Neoplastic Process | 0.41 | 0.405 | 0.793 | group |
MET | 4233 | Lung Neoplasms | C0024121 | Neoplastic Process | 0.4 | 0.405 | 0.793 | group |
MET | 4233 | Acute Myeloid Leukemia, M1 | C0026998 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Neoplasm Metastasis | C0027627 | Neoplastic Process | 0.4 | 0.405 | 0.793 | phenotype |
MET | 4233 | Experimental Hepatoma | C0086404 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Adenocarcinoma, Oxyphilic | C0205642 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Carcinoma, Cribriform | C0205643 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Carcinoma, Granular Cell | C0205644 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Adenocarcinoma, Tubular | C0205645 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Subependymal Giant Cell Astrocytoma | C0205768 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Juvenile Pilocytic Astrocytoma | C0280783 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Protoplasmic astrocytoma | C0334580 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Pilocytic Astrocytoma | C0334583 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Cryptogenic Chronic Hepatitis | C0524611 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | ovarian neoplasm | C0919267 | Neoplastic Process | 0.31 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of prostate | C0376358 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Chronic active hepatitis | C0520463 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of esophagus | C0546837 | Neoplastic Process | 0.34 | 0.405 | 0.793 | disease |
MET | 4233 | Collecting Duct Carcinoma of the Kidney | C1266044 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Glioblastoma Multiforme | C1621958 | Neoplastic Process | 0.37 | 0.405 | 0.793 | disease |
MET | 4233 | Astrocytoma | C0004114 | Neoplastic Process | 0.33 | 0.405 | 0.793 | disease |
MET | 4233 | Cognition Disorders | C0009241 | Mental or Behavioral Dysfunction | 0.3 | 0.405 | 0.793 | group |
MET | 4233 | Autistic Disorder | C0004352 | Mental or Behavioral Dysfunction | 0.6 | 0.405 | 0.793 | group |
MET | 4233 | Esophageal Neoplasms | C0014859 | Neoplastic Process | 0.32 | 0.405 | 0.793 | group |
MET | 4233 | Leukemia, Myelocytic, Acute | C0023467 | Neoplastic Process | 0.33 | 0.405 | 0.793 | disease |
MET | 4233 | Neuroblastoma | C0027819 | Neoplastic Process | 0.3 | 0.405 | 0.793 | group |
MET | 4233 | Prostatic Neoplasms | C0033578 | Neoplastic Process | 0.36 | 0.405 | 0.793 | group |
MET | 4233 | Anaplastic carcinoma | C0205696 | Neoplastic Process | 0.31 | 0.405 | 0.793 | disease |
MET | 4233 | Carcinoma, Spindle-Cell | C0205697 | Neoplastic Process | 0.31 | 0.405 | 0.793 | disease |
MET | 4233 | Carcinomatosis | C0205699 | Neoplastic Process | 0.3 | 0.405 | 0.793 | phenotype |
MET | 4233 | Malignant neoplasm of lung | C0242379 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Fibrillary Astrocytoma | C0334582 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant mesothelioma | C0345967 | Neoplastic Process | 0.34 | 0.405 | 0.793 | disease |
MET | 4233 | Chromophobe Renal Cell Carcinoma | C1266042 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Sarcomatoid Renal Cell Carcinoma | C1266043 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Osteofibrous Dysplasia | C1709353 | Disease or Syndrome | 0.41 | 0.405 | 0.793 | disease |
MET | 4233 | Copper-Overload Cirrhosis | C1876165 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Glioblastoma | C0017636 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.32 | 0.405 | 0.793 | disease |
MET | 4233 | Sinusitis | C0037199 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Chronic Persistent Hepatitis | C0149519 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Undifferentiated carcinoma | C0205698 | Neoplastic Process | 0.3 | 0.405 | 0.793 | phenotype |
MET | 4233 | Diffuse Astrocytoma | C0280785 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Gemistocytic astrocytoma | C0334581 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Childhood Cerebral Astrocytoma | C0338070 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Mixed oligoastrocytoma | C0547065 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Cerebral Astrocytoma | C0750935 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Intracranial Astrocytoma | C0750936 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of ovary | C1140680 | Neoplastic Process | 0.38 | 0.405 | 0.793 | disease |
MET | 4233 | Grade I Astrocytoma | C1704230 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Hereditary Diffuse Gastric Cancer | C1708349 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Acute Myeloid Leukemia (AML-M2) | C1879321 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | DEAFNESS, AUTOSOMAL RECESSIVE 97 | C4084709 | Disease or Syndrome | 0.6 | 0.405 | 0.793 | disease |
MET | 4233 | Malignant neoplasm of kidney | C0740457 | Neoplastic Process | 0.39 | 0.405 | 0.793 | disease |
MET | 4233 | Intellectual Disability | C3714756 | Mental or Behavioral Dysfunction | 0.3 | 0.405 | 0.793 | group |
MET | 4233 | Hereditary Papillary Renal Carcinoma | C0879257 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | Tibia, Bowing of, with Pseudarthrosis and Pectus Excavatum | C1836723 | Disease or Syndrome | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Papillary renal cell carcinoma, familial | C2931899 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Childhood Hepatocellular Carcinoma | C0279606 | Neoplastic Process | 0.4 | 0.405 | 0.793 | disease |
MET | 4233 | OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO | C4085248 | Finding | 0.3 | 0.405 | 0.793 | phenotype |
MET | 4233 | Malignant neoplasm of liver | C0345904 | Neoplastic Process | 0.32 | 0.405 | 0.793 | disease |
MET | 4233 | Hepatoblastoma Caused By Somatic Mutation | C2676033 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Hepatoblastoma | C0206624 | Neoplastic Process | 0.3 | 0.405 | 0.793 | disease |
MET | 4233 | Type 1 Papillary Renal Cell Carcinoma | C1336839 | Neoplastic Process | 0.32 | 0.405 | 0.793 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
MET | 4233 | [Crizotinib] | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | ABBV-399 | None | None | None |
MET | 4233 | ABT-700 | ABT-700 | CHEMBL3545419 | None |
MET | 4233 | ABT-700 | ABT-700 | CHEMBL3545419 | inhibitor |
MET | 4233 | ALECTINIB | ALECTINIB | CHEMBL1738797 | inhibitor |
MET | 4233 | Alvespimycin | ALVESPIMYCIN | CHEMBL383824 | None |
MET | 4233 | Afatinib | AFATINIB | CHEMBL1173655 | None |
MET | 4233 | Altiratinib | ALTIRATINIB | CHEMBL3545365 | None |
MET | 4233 | ALTIRATINIB | ALTIRATINIB | CHEMBL3545365 | inhibitor |
MET | 4233 | ALTIRATINIB | ALTIRATINIB | CHEMBL3545365 | inhibitor |
MET | 4233 | AM7 | AMOXICILLIN | CHEMBL1082 | inhibitor |
MET | 4233 | AMG-208 | AMG-208 | CHEMBL496102 | inhibitor |
MET | 4233 | AMG 0001 | None | None | None |
MET | 4233 | AMG 208 | AMG-208 | CHEMBL496102 | inhibitor |
MET | 4233 | AMG208 | AMG-208 | CHEMBL496102 | inhibitor |
MET | 4233 | AMG102 | RILOTUMUMAB | CHEMBL1743063 | None |
MET | 4233 | AMG-337 | AMG-337 | CHEMBL3545212 | inhibitor |
MET | 4233 | AMG-337 | AMG-337 | CHEMBL3545212 | inhibitor |
MET | 4233 | AMG 337 | AMG-337 | CHEMBL3545212 | None |
MET | 4233 | AMUVATINIB | AMUVATINIB | CHEMBL2103851 | None |
MET | 4233 | Amuvatinib | AMUVATINIB | CHEMBL2103851 | None |
MET | 4233 | AMUVATINIB | AMUVATINIB | CHEMBL2103851 | inhibitor |
MET | 4233 | AMUVATINIB | AMUVATINIB | CHEMBL2103851 | inhibitor |
MET | 4233 | AMUVATINIB | AMUVATINIB | CHEMBL2103851 | inhibitor |
MET | 4233 | ANTI-CMET | None | None | antibody |
MET | 4233 | ANTI-EGFR MONOCLONAL ANTIBODY | None | None | None |
MET | 4233 | ARQ 197 | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | ARQ-197 | TIVANTINIB | CHEMBL2103882 | None |
MET | 4233 | ARRY-300 | ARRY-300 | CHEMBL3545359 | inhibitor |
MET | 4233 | ARQ 197 | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | ARGX-111 | None | None | None |
MET | 4233 | ARQ 197 | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | AZD9291 | OSIMERTINIB | CHEMBL3353410 | None |
MET | 4233 | Bevacizumab | BEVACIZUMAB | CHEMBL1201583 | None |
MET | 4233 | BEZ235 | DACTOLISIB | CHEMBL1879463 | None |
MET | 4233 | BMS-777607 | BMS-777607 | CHEMBL460702 | inhibitor |
MET | 4233 | BMS-698769 | BMS-698769 | CHEMBL3545299 | inhibitor |
MET | 4233 | BMS-777607 | BMS-777607 | CHEMBL460702 | inhibitor |
MET | 4233 | BMS-794833 | BMS-794833 | CHEMBL3545119 | inhibitor |
MET | 4233 | BMS777607 | BMS-777607 | CHEMBL460702 | inhibitor |
MET | 4233 | BMS-777607 | BMS-777607 | CHEMBL460702 | None |
MET | 4233 | BMS-777607 | BMS-777607 | CHEMBL460702 | inhibitor |
MET | 4233 | BMS-817378 | BMS-817378 | CHEMBL3545050 | inhibitor |
MET | 4233 | BPI-9016 | BPI-9016 | CHEMBL3545236 | inhibitor |
MET | 4233 | CABOZANTANIB | None | None | None |
MET | 4233 | Cabozantinib | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB S-MALATE | CABOZANTINIB S-MALATE | CHEMBL2103868 | inhibitor |
MET | 4233 | Cabozatinib | None | None | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | Cabozantinib | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | cabozantinib | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | CABOZANTINIB | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | Cabozantinib | CABOZANTINIB | CHEMBL2105717 | None |
MET | 4233 | Capecitabine | CAPECITABINE | CHEMBL1773 | None |
MET | 4233 | Cetuximab | CETUXIMAB | CHEMBL1201577 | None |
MET | 4233 | CETUXIMAB | CETUXIMAB | CHEMBL1201577 | None |
MET | 4233 | Carboplatin | CARBOPLATIN | CHEMBL1351 | None |
MET | 4233 | CAPMATINIB | CAPMATINIB | CHEMBL3188267 | inhibitor |
MET | 4233 | CAPMATINIB | CAPMATINIB | CHEMBL3188267 | inhibitor |
MET | 4233 | Capmatinib | CAPMATINIB | CHEMBL3188267 | None |
MET | 4233 | CAPMATINIB | CAPMATINIB | CHEMBL3188267 | None |
MET | 4233 | CO1686 | ROCILETINIB | CHEMBL3545308 | None |
MET | 4233 | COMETRIQ | CABOZANTINIB | CHEMBL2105717 | inhibitor |
MET | 4233 | COMPOUND 16 [PMID: 18945615] | None | None | inhibitor |
MET | 4233 | COMPOUND 1O [PMID: 24210504] | None | None | inhibitor |
MET | 4233 | COMPOUND 27 [PMID: 21123062] | None | None | inhibitor |
MET | 4233 | COMPOUND R-16 [PMID: 21967808] | None | None | inhibitor |
MET | 4233 | Crizotinib | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | Crizotinib | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | inhibitor |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | inhibitor |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | inhibitor |
MET | 4233 | CRENOLANIB | CRENOLANIB | CHEMBL2105728 | inhibitor |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | Crizotinib | CRIZOTINIB | CHEMBL601719 | None |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | inhibitor |
MET | 4233 | CRIZOTINIB | CRIZOTINIB | CHEMBL601719 | inhibitor |
MET | 4233 | Dasatinib | DASATINIB | CHEMBL1421 | None |
MET | 4233 | EMD 1204831 | EMD-1204831 | CHEMBL3545053 | None |
MET | 4233 | EMD1214063 | Tepotinib | CHEMBL3402762 | inhibitor |
MET | 4233 | Emibetuzumab | EMIBETUZUMAB | CHEMBL3301578 | None |
MET | 4233 | EMD 1214063 | Tepotinib | CHEMBL3402762 | None |
MET | 4233 | EMD-1204831 | EMD-1204831 | CHEMBL3545053 | inhibitor |
MET | 4233 | EMIBETUZUMAB | EMIBETUZUMAB | CHEMBL3301578 | antibody |
MET | 4233 | ENSARTINIB | None | None | inhibitor |
MET | 4233 | Erlotinib | ERLOTINIB | CHEMBL553 | None |
MET | 4233 | FF-284 | None | None | None |
MET | 4233 | Ficlatuzumab | FICLATUZUMAB | CHEMBL1743018 | None |
MET | 4233 | Fluorouracil | FLUOROURACIL | CHEMBL185 | None |
MET | 4233 | FORETINIB | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | FORETINIB | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | FORETINIB | FORETINIB | CHEMBL1230609 | None |
MET | 4233 | FORETINIB | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | Foretinib | FORETINIB | CHEMBL1230609 | None |
MET | 4233 | FORETINIB | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | Ganetespib | GANETESPIB | CHEMBL2103879 | None |
MET | 4233 | GE-137 | None | None | None |
MET | 4233 | Gefitinib | GEFITINIB | CHEMBL939 | None |
MET | 4233 | GEFITINIB | GEFITINIB | CHEMBL939 | None |
MET | 4233 | GLESATINIB | CLOFIBRATE | CHEMBL565 | inhibitor |
MET | 4233 | Golvatinib | GOLVATINIB | CHEMBL3039525 | None |
MET | 4233 | GOLVATINIB | GOLVATINIB | CHEMBL3039525 | inhibitor |
MET | 4233 | GOLVATINIB | GOLVATINIB | CHEMBL3039525 | inhibitor |
MET | 4233 | GSK1363089 | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | HEPATOCYTE GROWTH FACTOR | None | None | None |
MET | 4233 | Imatinib | IMATINIB | CHEMBL941 | None |
MET | 4233 | INCB028060 | CAPMATINIB | CHEMBL3188267 | None |
MET | 4233 | INC280 | CAPMATINIB | CHEMBL3188267 | None |
MET | 4233 | INCB028060 | CAPMATINIB | CHEMBL3188267 | inhibitor |
MET | 4233 | INCB28060 | CAPMATINIB | CHEMBL3188267 | inhibitor |
MET | 4233 | INC280 | CAPMATINIB | CHEMBL3188267 | inhibitor |
MET | 4233 | JNJ 38877605 | JNJ-38877605 | CHEMBL2133806 | None |
MET | 4233 | KRC-00715 | None | None | None |
MET | 4233 | KTN0073-IgG1 | None | None | None |
MET | 4233 | KRC-00509 | None | None | None |
MET | 4233 | Lapatinib | LAPATINIB | CHEMBL554 | None |
MET | 4233 | Lapatinib | LAPATINIB | CHEMBL554 | None |
MET | 4233 | Leucovorin | LEUCOVORIN | CHEMBL1679 | None |
MET | 4233 | JNJ38877605 | JNJ-38877605 | CHEMBL2133806 | inhibitor |
MET | 4233 | JNJ38877605 | JNJ-38877605 | CHEMBL2133806 | inhibitor |
MET | 4233 | JNJ-38877605 | JNJ-38877605 | CHEMBL2133806 | inhibitor |
MET | 4233 | JNJ-61186372 | None | None | None |
MET | 4233 | K252a | K-252A | CHEMBL281948 | None |
MET | 4233 | KTN0073-IgG2 | None | None | None |
MET | 4233 | LY2875358 | LY-2875358 | CHEMBL2109517 | antibody |
MET | 4233 | LY2801653 | MERESTINIB | CHEMBL3545307 | None |
MET | 4233 | LY2875358 | LY-2875358 | CHEMBL2109517 | antibody |
MET | 4233 | M-COPA | None | None | None |
MET | 4233 | MERESTINIB | MERESTINIB | CHEMBL3545307 | inhibitor |
MET | 4233 | MET INHIBITION, ERBB3 INHIBITION | None | None | None |
MET | 4233 | METMAB | ONARTUZUMAB | CHEMBL1743051 | None |
MET | 4233 | METMAB | ONARTUZUMAB | CHEMBL1743051 | antibody |
MET | 4233 | MGCD265 | MGCD-265 | CHEMBL254760 | inhibitor |
MET | 4233 | MGCD265 | MGCD-265 | CHEMBL254760 | inhibitor |
MET | 4233 | MGCD265 | MGCD-265 | CHEMBL254760 | None |
MET | 4233 | MGCD265 | MGCD-265 | CHEMBL254760 | inhibitor |
MET | 4233 | mFOLFOX6 | None | None | None |
MET | 4233 | MGCD-265 | MGCD-265 | CHEMBL254760 | inhibitor |
MET | 4233 | MGCD265 | MGCD-265 | CHEMBL254760 | None |
MET | 4233 | MK-2461 | MK-2461 | CHEMBL1822792 | inhibitor |
MET | 4233 | MK-2461 | MK-2461 | CHEMBL1822792 | inhibitor |
MET | 4233 | MK-2461 | MK-2461 | CHEMBL1822792 | inhibitor |
MET | 4233 | MK-8033 | MK-8033 | CHEMBL2323775 | inhibitor |
MET | 4233 | MK-8033 | MK-8033 | CHEMBL2323775 | inhibitor |
MET | 4233 | MK2461 | MK-2461 | CHEMBL1822792 | inhibitor |
MET | 4233 | MP470 | AMUVATINIB | CHEMBL2103851 | inhibitor |
MET | 4233 | MTERON-F1 | RILONACEPT | CHEMBL1201830 | stimulator |
MET | 4233 | MSC2156119J | Tepotinib | CHEMBL3402762 | None |
MET | 4233 | None | None | None | None |
MET | 4233 | None | None | None | None |
MET | 4233 | NPS-1034 | None | None | None |
MET | 4233 | Olaparib | OLAPARIB | CHEMBL521686 | None |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | None |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | antibody |
MET | 4233 | Onartuzumab | ONARTUZUMAB | CHEMBL1743051 | None |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | antibody |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | inhibitor |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | antagonist |
MET | 4233 | ONARTUZUMAB | ONARTUZUMAB | CHEMBL1743051 | antibody |
MET | 4233 | Osimertinib | OSIMERTINIB | CHEMBL3353410 | None |
MET | 4233 | Oxaliplatin | OXALIPLATIN | CHEMBL414804 | None |
MET | 4233 | Paclitaxel | PACLITAXEL | CHEMBL428647 | None |
MET | 4233 | Panitumumab | PANITUMUMAB | CHEMBL1201827 | None |
MET | 4233 | Panitumumab | PANITUMUMAB | CHEMBL1201827 | None |
MET | 4233 | PF-04217903 | PF-04217903 | CHEMBL2001019 | inhibitor |
MET | 4233 | PF-4217903 | PF-04217903 | CHEMBL2001019 | inhibitor |
MET | 4233 | PF-04217903 | PF-04217903 | CHEMBL2001019 | inhibitor |
MET | 4233 | PHA-665752 | PHA-665752 | CHEMBL450786 | inhibitor |
MET | 4233 | PHA-665752 | PHA-665752 | CHEMBL450786 | None |
MET | 4233 | PF-4217903 | PF-04217903 | CHEMBL2001019 | inhibitor |
MET | 4233 | PP-121 | CHEMBL1081312 | CHEMBL1081312 | None |
MET | 4233 | Ponatinib | PONATINIB | CHEMBL1171837 | None |
MET | 4233 | Radiotherapy | None | None | None |
MET | 4233 | Rociletinib | ROCILETINIB | CHEMBL3545308 | None |
MET | 4233 | S-49076 | None | None | None |
MET | 4233 | Rucaparib | RUCAPARIB | CHEMBL1173055 | None |
MET | 4233 | SAR-125844 | SAR-125844 | CHEMBL3545325 | inhibitor |
MET | 4233 | SAR125844 | SAR-125844 | CHEMBL3545325 | None |
MET | 4233 | SAVOLITINIB | Savolitinib | CHEMBL3545336 | None |
MET | 4233 | Savolitinib | Savolitinib | CHEMBL3545336 | inhibitor |
MET | 4233 | Savolitinib | Savolitinib | CHEMBL3545336 | None |
MET | 4233 | Selumetinib | SELUMETINIB | CHEMBL1614701 | None |
MET | 4233 | SELUMETINIB, TRAMETINIB | None | None | None |
MET | 4233 | SGX523 | SGX-523 | CHEMBL1236107 | None |
MET | 4233 | SGX523 | SGX-523 | CHEMBL1236107 | inhibitor |
MET | 4233 | SGX-523 | SGX-523 | CHEMBL1236107 | inhibitor |
MET | 4233 | SGX523 | SGX-523 | CHEMBL1236107 | None |
MET | 4233 | SGX-523 | SGX-523 | CHEMBL1236107 | inhibitor |
MET | 4233 | Sorafenib | SORAFENIB | CHEMBL1336 | None |
MET | 4233 | SU11274 | PYRAZINAMIDE | CHEMBL614 | inhibitor |
MET | 4233 | SU11274 | PYRAZINAMIDE | CHEMBL614 | None |
MET | 4233 | SYM015 | None | None | None |
MET | 4233 | TAE226 | CHEMBL458997 | CHEMBL458997 | None |
MET | 4233 | TAK-701 | None | None | antibody |
MET | 4233 | TANESPIMYCIN | TANESPIMYCIN | CHEMBL109480 | inhibitor |
MET | 4233 | Tepotinib | Tepotinib | CHEMBL3402762 | inhibitor |
MET | 4233 | TEPOTINIB | Tepotinib | CHEMBL3402762 | inhibitor |
MET | 4233 | TAS-115 | TAS-115 | CHEMBL3545144 | inhibitor |
MET | 4233 | TAS-115 | TAS-115 | CHEMBL3545144 | None |
MET | 4233 | TIVANTINIB | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | TIVANTINIB | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | TIVANTINIB | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | TIVANTINIB | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | TIVANTINIB | TIVANTINIB | CHEMBL2103882 | inhibitor |
MET | 4233 | Trametinib | TRAMETINIB | CHEMBL2103875 | None |
MET | 4233 | Trastuzumab | TRASTUZUMAB | CHEMBL1201585 | None |
MET | 4233 | Trastuzumab | TRASTUZUMAB | CHEMBL1201585 | None |
MET | 4233 | Vemurafenib | VEMURAFENIB | CHEMBL1229517 | None |
MET | 4233 | VEMURAFENIB | VEMURAFENIB | CHEMBL1229517 | None |
MET | 4233 | Veliparib | VELIPARIB | CHEMBL506871 | None |
MET | 4233 | XL880 | FORETINIB | CHEMBL1230609 | None |
MET | 4233 | XL880 | FORETINIB | CHEMBL1230609 | inhibitor |
MET | 4233 | XL147 | PILARALISIB (CHEMBL3218575) | CHEMBL3218575 | None |